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Human retroposons of the Alu family also contain an inter- Abstract Internal promoters of some genes transcribed by RNA 
nal promoter for RNA polymerase III having A- and B- polymerase II I  (e.g. tRNA genes, adenovirus VA1 RNA gene, 
human retroposons of the Alu family) contain a conserved boxes homologous to the elements in tRNA genes [10] which 
sequence element, B-box, interacting with basal transcription were demonstrated to be important for Alu transcription in 
factor TFIIIC2 which initiates assembly of the full transcription vitro [11,12]. However, Alu repeats are very poorly tran- 
complex on the genes, and which represents the major scribed in vivo [13] and we have previously presented evidence 
determinant of the efficiency of their expression. In this study for the existence of a negative control of Alu transcription 
we have identified in human nuclear extracts a protein which mediated by an Alu-binding protein [14,15]. One apparent 
interacts with VA1 B-box DNA and forms a high-affinity possibility for such control is interference of the protein 
complex which is very stable after the addition of a large excess with binding to the Alu B-box of TFI I IC2, and in an attempt 
of competitor DNA. Unlike TFII IC2, the B-box-binding activity 
of the B-box-binding protein is found to be decreased in to develop a biologically relevant assay for the binding inter- 
adenovirus 5-transformed human cells. In these cells (line 293) ference we used in electrophoretic mobility shift assays an 
increased transcription of VA1 and tRNA genes in vivo and in oligonucleotide covering the palindromic VA1 promoter se- 
vitro was previously detected by other workers. Our results quence with a centered B-box identical in sequence to oligo- 
suggest that besides TFIIIC2, an additional B-box-binding nucleotides used for the affinity purification of TFI I IC2 [5,6]. 
protein factor may be involved in the regulation of expression The results of the analysis of human nuclear extracts for pro- 
of the RNA polymerase III-transcribed genes, teins interacting with this oligonucleotide are presented in this 
study. 
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factor TFI I IC2 
Human cells (lung adenocarcinoma MCF7, kidney carcinoma 
OKP-GS and adenovirus 5-transformed embryonal kidney cells line 
293) were obtained from ATCC and maintained in DMEM medium 
1. Introduction containing (if not otherwise indicated) 10% of bovine fetal serum. 
Nuclear extracts were prepared from the cells by a micro-method 
Some RNA-coding genes transcribed by RNA polymerase consisting of three steps: (1) after washing in PBS cells were incubated 
in hypotonic buffer A (20 mM HEPES buffer, pH 7.9, 10 mM MgCI2, 
III contain an internal promoter composed of two properly 10 mM dithiothreitol/DDT, 1 mM phenylmethylsulfonyl fluoride/ 
spaced conserved sequence motifs, an upstream element PMSF) for 20 min on ice, disrupted by passing 10 times through a 
named the A-box and a downstream element called the B- 24 gauge needle and the nuclear pellet collected by centrifugation for 
box, which are essential for efficient transcription [1,2]. The 10-20 s in an Eppendorf centrifuge; (2) the pellet was resuspended in 
B-box of tRNA genes and of adenovirus VA1 gene is known buffer B (20 mM HEPES buffer, pH 7.9, 10 mM DTT, 0.45 M NaCI, 
1 mM PMSF), incubated for 30 rain on ice and extracted nuclei 
to bind mammalian basal transcription factor TFI I IC2 [3] separated by 20 s centrifugation i an Eppendorf centrifuge; (3) the 
which was suggested to initiate assembly of the full transcrip- supernatant was dialysed for 2 h at 4°C against buffer D (20 mM 
tion complex recruiting RNA polymerase III and containing HEPES buffer, pH 7.9, 100 mM NaC1, 10 mM DTT, 1 mM PMSF), 
TFI I IC1 and TFI I IB [4]. Mammalian TFI I IC2 contains five aliquoted and stored at -80°C. 
All oligonucleotides were synthesized using a Phamacia Gene As- protein subunits [5,6] and the DNA-binding 20 kDa subunit sembler and, if necessary, purified using FPLC on a column of Mono 
of the factor (TFII IC2a) has recently been cloned and se- Q. The sequence of the self-complementary oligonucleotide from 
quenced [7,8]. Some workers [6,9] have identified two forms which the duplex VB1 substrate was prepared is (5' to 3' here and 
of TFI I IC2, one of which (TFII IC2a) was active in an in vitro elsewhere) GACGACCGGGGTTGGAACCCC; top strand sequence 
transcriptional assay, the other (TFII IC2b) being inactive in tVADB1, GTTCGAACCCCGGATCCGGCC; bottom strand se- 
quence bVADB1, ATCACGGCGGACGGCCGGATC; top strand 
the assay. Both forms were found to bind VA1 promoter B- sequence tAP3, GATCTGTGGAAAGTCCCA; bottom strand se- 
box with an equal affinity [6]. An active form of the factor quence bAP3, GATCTGGGACTTTCCACA; top strand sequence 
(TFII IC2a) was also found to contain a distinct subunit of tAP1, GATCGTGACTCAGCGC and bottom strand sequence 
110 kDa [6,9] and the presence of this subunit (TFIIICI~) in bAP1, GATCGCGCTGAGTCAC. Labeled duplex oligonucleotides 
for electrophoric mobility shift assays (VB1 and VADB1) were pre- some fractions of a partially purified TFI I IC2 was found to pared in the following way. First, the top strand was labeled with 32p 
correlate with the efficiency of RNA polymerase III-depen- using phage T4 polynucleotide kinase and [7-32P]ATP, the kinase was 
dent transcription in the corresponding crude nuclear extracts inactivated by heating, the bottom strand was added and annealed to 
[9]. the labeled strand, all four unlabeled NTPs added along with Kle- 
now fragment of E. coli DNA polymerase I and incubation continued 
for 1 h at room temperature (RT). Then duplex substrate was purified 
*Corresponding author. Fax: (7) (812) 2470341. using a column of Sephadex G-25. Unlabeled competitor duplex oli- 
E-mail: tom@ic.spb.su gonucleotides VB1 and VADB1 were prepared in the same way except 
0014-5793/96/$12.00 © 1996 Federation of European Biochemical Societies. All rights reserved. 
P I IS0014-5793(96)00353-5  
44 A.V. Kropotov, N.V. TomilinlFEBS Letters 386 (1996) 43-46 
for incubation with kinase. Unlabeled uplex AP3 and AP1 compe- A 
titors were prepared by annealing of the corresponding complemen- B-box 
tary strands. '"****'**** 
Electrophoretic mobility shift assay (EMSA) was performed by in- 5' GC~GGACGACCGGGGTTCGAACCCCGGATCCGGCCGTCCGCCGTGAT. - V I gene 
. . . . . . . . . . . . . . . .  >< . . . . . . . . . . . . . . . . .  inverted repeat 
cubation for 30 min at room temperature of labeled duplex oligonu- duplex DNA 
cleotide (2-3 ng) in mixtures (20 I11) containing 12 mM HEPES buffer, substrates 
pH 7.9, I mM EDTA, 100 mM NaC1, 0.2 mM DTT, 10% Ficoll, 100 vB1 - GACCGGGGTTCGAACCCCGG 
VADB I - GTTCGAACCCCGGATCCGCrCCGTCC GCCGTGAT 
ktg/ml bovine serum albumin, nuclear extract (1-4 ktl, 1.5 6 ~tg of total 
protein) and varying amounts of unlabeled competitor as indicated in 
the figure legends. Complexes were then separated in a low salt (22 
mM Tris, 22 mM boric acid, 0.6 mM EDTA) 4% polyacrylamide g l, B 
the gel being dried and radioautographed. 
3. Results 0.6 / / "  
bound ~" • 
In electrophoretic mobility shift assay (EMSA) experiments DNA 
(nM) / 
with the VA1 B-box oligonucleotide (VB1) and crude human / 03 Kapp= 27x109 M- I  
nuclear extracts as a source of proteins, we expected to see a -~° 
low mobility band representing the complex of TFI I IC2 (of / 
about 600 kDa, see [5,6]) with the DNA.  However, under our ~s J l 0  
binding conditions with labeled VB1 EMSA substrate we ob- vm DNA . . . . . .  tration(nM) 
served (Fig. 1A,C, lane 1) a major complex (CB) of rather Fig. 2. (A) Adenovirus VA1 gene sequence covering promoter B- 
high mobility the formation of which was completely sup- box and sequences of DNA substrates used in EMSA. (B) Measure- 
pressed by simultaneous addition of a 100-fold molar excess ment of the equilibrium constant of the formation of the CB com- 
plex (bound DNA, [CDs]) with the VB1 binding substrate. Kapp was 
of unlabeled VB1 (Fig. 1C, lane 2), and only weakly sup- calculated from the equation [CDs]=[C°]X[Ds]×K,~pp/I+K~pp×[Ds] 
pressed by simultaneous addition of a 100-fold molar excess as described in [3], where [Ds] is the concentration of unbound VB1 
of unspecific duplex oligonucleotide AP1 (Fig. 1C, lane 4). In and [C °] is the concentration of all VBl-binding sites in the proteins 
order to confirm that the observed complex CB (Fig. 1A) is added. [C °] is calculated to be 0.74 nM. EMSA was performed (see 
actually formed by a B-box-binding protein, we used in section 2 with variable amounts of the labeled VB1 substrate (0.2-4 
ng per 20 p.1 incubation mixture) and fixed amount of nuclear ex- 
EMSA another VA1 promoter-derived oligonucleotide sub- tract from MCF7 cells (3 ktg of protein). After separation, bands of 
strate (VADB1) and found (Fig. 1B) that under the same CB and of free VB1 were located by autoradiography and radioac- 
conditions this substrate forms a similar complex and a 100- tivity was measured in a scintillation counter. 
fold molar excess of unlabeled VADB1 strongly suppresses 
the formation of a complex with labeled VB1 (Fig. 1C, lane downstream from the VA1 B-box are not very important for 
3). It can be seen from Fig. 2A that the VB1 and VADB1 the formation of CB, and the incomplete suppression of CB 
sequences overlap only over the B-box sequence which is ap- formation by VADB1 competitor (Fig. 1C, lane 3) suggests a
parently responsible for the EMSA complex observed here possible role of the VA1 sequence located just upstream of the 
(CB). The results also indicate that sequences located just B-box. To distinguish the observed B-box-binding activity 
from the TFII IC-copurifying zinc-finger B-box-binding pro- 
C tein having a 55 kDa DNA binding subunit [16], we analysed 
A B whether CB formation may be suppressed by treatment of the 
1 2 nuclear extract with l0 mM EDTA which has been shown to 
1 2 1 2 3 4 inhibit the B-box-binding activity of p55 [16]. CB formation 
was found to be unaffected by this EDTA treatment (not 
shown), indicating that the corresponding protein is different 
from p55. 
CB To quantitate the binding reaction observed we measured 
the concentrations of free and bound VB1 substrate after the CB- CB [ 
addition of a fixed amount of nuclear extract and different 
amounts of the substrate as described for purified TFI I IC2 
in [3]. Radioactive DNA contents of the EMSA bands was 
free measured by liquid scintillation counting. Fig. 2B shows the 
results on CB complexes (bound DNA),  and the data ob- r 
DNA[ free tained allowed [3] us to calculate the apparent equilibrium 
VB1 [ constant of the binding reaction (Kapp) which was found to VB 1 VADB 1 
be 2.7 × 109 M -1 as well as the concentration of all B-box 
Fig. 1. Complexes formed by a protein from the nuclear extract of DNA-binding sites in reactions ([C°]) which was found to 
OKP-GS cells with the adenovirus VAl-gene B-box oligonucleotides 
VB1 (A,C) and VADB1 (B). All variants contained 3 ng of labeled be 0.74 nM. The indicated Kapp value is only one order of 
oligonucleotide, 2 lal (3 p,g of protein) of nuclear extract and other magnitude lower than that measured for purified TFI I IC2 [3]. 
components as indicated in section 2. In (A,B) lanes 1 contained no Additional data on the stability of CB were obtained in the 
competitor; and lanes 2, 50 ng of sonicated unlabeled bovine DNA. EMSA experiments in which an excess of unlabeled competi- 
In (C) all lanes contained 50 ng of the indicated DNA plus 300 ng 
of unlabeled VB1 oligonucleotide (lane 2), 300 ng of unlabeled tor (sonicated bovine DNA,  1 mg/ml final concentration) was 
VADB1 (lane 3) or 300 ng of AP1 (lane 4). The major detected added to pre-formed complex of labeled VB1 with protein and 
complex is marked as CB. decay of the complex at room temperature was followed with 
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1 2 3 4 5 transformation [20-22]. Therefore, suppression of formation 
of complex CB in EMSA experiments with crude nuclear ex- 
. . . . . . . . .  tracts correlates with increased transcription of class III genes 
by RNA polymerase III. We also compared CB formation by 
extracts from human MCF-7 cells grown at normal 10% se- 
rum concentration (Fig. 4B, lanes 1-2) or at 0.5% serum (Fig. 
4B, lanes 3-4) and found that although CB is not greatly 
affected by low serum concentration, stimulation of additional 
high- and low-mobility complexes (Fig. 4B, lanes 3~,, de- 
noted as CX and *) takes place. Growth of cells at low serum 
concentration was reported to decrease RNA polymerase i i i -  
CB  - dependent transcriptional activity of nuclear extracts [9]. 
4. D iscuss ion  
In this study a novel B-box-binding activity has been iden- 
tified in human cells and the activity is found to be down- 
regulated after adenovirus transformation when transcription 
of all class III genes is known to be stimulated. This activity 
seems not to be associated with the well known basal tran- 
scription factor TFI I IC2 having a very large (220 kDa) DNA-  
free binding subunit [5,6], or with B-box-binding protein p55 co- 
purifying with TF I I IC  transcriptional ctivity [16], and, there- 
DNA fore, seems to be associated with a distinct protein which we 
. . . . . . .  ~ .... refer to here as BBP-D. This protein in vitro binds B-box with 
Fig. 3. Stability of the pre-formed CB complex with VB1 substrate an affinity comparable to that of the purified TFI I IC2 and 
after subsequent addition of an excess of unlabeled competitor. The may affect functions of this basal complex which were sug- 
incubation mixture (100 lal) contained labeled VB1 (5 ng), MCF7 gested to be important for efficient expression of some RNA 
nuclear extract (25 ~tg of protein) and other components as de- polymerase III-transcribed genes. It remains unclear why un- 
scribed in section 2. After 30 min at room temperature 10 ~tl (100 der our binding conditions the complex of VB1 with TFI I IC2 
~tg) of unlabeled sonicated bovine DNA was added, and 20-ktl ali- 
quots of the mixture were loaded onto a 4% polyacrylamide running was not simultaneously detected. One possibility is that VA1 
gel after 0 min (lane 1), 20 min (lane 2), 40 min (lane 3), 80 min sequences located just upstream of the B-box and absent from 
(lane 4) and 120 min of incubation at room temperature, the VB1 substrate are also important for TFI I IC2 binding in 
crude nuclear extracts. Corresponding DNase footprints over 
VA1 promoter obtained with purified TFI I IC2 or crude nu- 
clear extract [3,23] cover a rather long (40 nucleotides) region 
time (Fig. 3). It can be seen that CB does not dissociate ven 
at 2 h after addition of the competitor (Fig. 3, lane 5). CB was 
also found to be stable for at least 1 h after addition of a 100- m B 
fold molar excess of unlabeled VB 1 (not shown). Interestingly, 
some increases in a complex having a slightly higher mobility 1 2 3 4 5 6 1 2 3 4 
in EMSA than CB (Fig. 3, *) were observed uring incubation . . . . . .  
with the competitor suggesting the possible conversion of CB CX [ 
into this complex with higher mobility. The complex of puri- 
fied TFI I IC2 with full VA1 promoter was reported to decay CB- 
completely within 1 h after the addition of a 100-fold molar CB - . 
excess of unlabeled B-box oligonucleotide [17], indicating that 
CB is more stable in this assay than the complex formed by 
purified TFI I IC2 with VA1 promoter. 
To investigate the possible biologival relevance of the com- 
flee free plex CB, we compared extracts from cultivated human embry- VB1 
onal kidney cells transformed with adenovirus 5 (line 293) and VB1 
control non-transformed kidney cells (line OKP-GS). Under - - - 
identical binding conditions and protein concentration, ex- Fig. 4. Influence of adenovirus transformation (A) and of low con- 
tracts from 293 cells were found to contain less CB-forming centration of serum (B) on formation of the CB complex with VB1 
EMSA substrate. (A) Nuclear extracts were prepared from control 
activity than those from control cells (Fig. 4A), indicating that (line OKP-GS) and adenovirus-transformed (line 293) human cells, 
protein responsible for CB formation is downregulated after and total protein concentration i the extracts was adjusted to 1.5 
adenovirus transformation. B-box-binding and transcriptional mg/ml. EMSA was performed with fixed amount of all components 
activity associated with TFI I IC2 has been reported to be in- except variable amounts of nuclear extracts which was 1 ktl (lanes 
1,4), 2 ~tl (lanes 2,5) and 4 p.1 (lanes 3,6). (B) Nuclear extracts were 
creased [18] or to remain unchanged [9,19] in adenovirus- prepared from MCF7 cells grown at 10% serum (lanes 1,2) or 0.5% 
transformed cells, and transcription of all B-box-containing serum (lanes 3,4) and 1.5 ~tg (lanes 1,3) or 3 ktg (lanes 2,4) of pro- 
genes is known to be strongly stimulated after adenovirus tein was added to otherwise identical incubation mixtures. 
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with a centered B-box consistent with this view, but other [4] Dean, N. and Berk, A.J. (1988) Mol. Cell. Biol. 8, 3017-30251. 
explanations are also possible. [5] Yoshinaga, S., L'Etoile, N.D. and Berk, A.J. (1987) J. Biol. 
Chem. 264, 10726-10731. 
A correlation between RNA polymerase III-dependent [6] Kovelman, R. and Roeder, R.G. (1992) J. Biol. Chem. 267, 
transcriptional ctivity of nuclear extracts and the presence 24446-24456. 
of 110 kDa 13-subunit n TFI I IC2 have recently been demon- [7] Lagna, G.R., Kovelman, R., Sukegawa, J. and Roeder, R.G. 
strated for human cells expressing or not expressing adeno- (1994) Mol. Cell. Biol. 14, 3053-3064. 
virus E1A gene, and for cells grown at low and normal con- [8] L'Etoile, N.D., Fahnestock, M.L., Shen, R., Abersold, R. and 
Berk, A.J. (1994) Proc. Natl. Acad. Sci. USA 91, 1652 1656. 
centration of serum [9]. This observation was interpreted as [9] Sinn, E., Wang, Z., Kovelman, R. and Roeder, R.G. (1995) 
evidence that TFI I IC2 activity is regulated by this subunit [9] Genes Devel. 9, 675 685. 
but a potential role of other factors affected by E1A or serum [10] Schmidt, C.W. and Maraia, R. (1992) Cur. Opin. Genet. Devel. 
2, 874-882. 
was not excluded. TFI I IC2 activity in the in vitro transcrip- [ll] Perez-Stable, C., Ayres, T.M. and Shen, C.-K.J. (1984) Proc. 
tion assay is known to be modulated by its phosphorylation/ Natl. Acad. Sci. USA 81, 5291-5295. 
dephosphorylation [19,24], and adenovirus E1A expression [12] Perez-Stable, C. and Shen C.-K.J. (1986) Mol. Cell. Biol. 6, 
induces a very complex response including phosphorylation- 2041-2052. 
mediated activation of some transcription factors [25]. Inter- [13] Liu, W.-M., Maraia, R.J., Rubin, C. and Schmidt, C.W. (1994) 
Nucleic Acids Res. 22, 1087-1095. estingly, phosphorylation-mediated inactivation of an RNA [14] Tomilin, N. and Bozhkov, V. (1989) FEBS Lett. 251, 79 83. 
polymerase II transcriptional repressor ERF was recently de- [15] Tomilin, N., Iguchi-Agira, S. and Agira, H. (1990) FEBS Lett. 
monstrated [26]. Therefore, downregulation of BBP-D in ade- 263, 69-72. 
novirus-transformed cells may be also important for activa- [16] Waldschmidt, R., Schneider, H.R. and Seifart, K.H. (1990) Nu- 
tion of RNA polymerase III-dependent transcription and a cleic Acids Res. 19, 1455-1459. 
[17] Boulanger, P.A., L'Etoile, N.D. and Berk, A.J. (1989) Nucleic 
potential role of factors different from TFI I IC2 is not ex- Acids Res. 17, 7761 7770. 
cluded by the observations of others [9]. Purification of [18] Yoshinaga, S.N., Dean, N., Han, M. and Berk, A.J. (1986) 
BBP-D as well as cloning and analysis of corresponding EMBO J. 5, 343-354. 
gene may be helpful to understand the mechanism of regula- [19] Hoeffler, W.K., Kovelman, R. and Roeder, R.G. (1988) Cell 53, 
907-920. tion of transcription of the B-box-containing genes in vivo. [20] Gaynor, R.B., Feldman, L.T. and Berk A.J. (1985) Science 230, 
447450. 
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